Sylviane Muller, a world-renowned researcher in immunology and medicinal chemistry, has been elected to the Academy of Sciences. This prestigious honor recognizes her exceptional career, marked by major contributions to the fight against autoimmune diseases.
Sylviane Muller, a research director emerita at the CNRS and the University of Strasbourg, is an iconic figure in French biomedical research. She has dedicated her career to studying the mechanisms of autoimmunity and developing innovative therapies, particularly for systemic lupus erythematosus. This chronic autoimmune disease, which affects more than 5 million people worldwide, is at the heart of her research. Together with her team, she has discovered a promising therapeutic molecule, which is now in an advanced clinical trial phase.
Her expertise extends to immunopeptides, synthetic vaccines, and targeted therapeutic strategies. As a co-holder of more than 30 patents, she has co-founded two companies in the pharmaceutical sector, demonstrating a consistent commitment to translating scientific findings into benefits for patients.
After earning a BTS in biological analysis in 1973, Sylviane Muller joined a university laboratory, where a colleague encouraged her to return to school. This turning point led her from a master’s degree in biochemistry to a dissertation in molecular biology, a postdoctoral fellowship at the Max Planck Institute for Immunology in Freiburg, Germany, followed by a doctorate in science. Upon her return to Strasbourg, she turned her attention to immunology, a field to which she would make decisive contributions.
From 2001 to 2017, she headed the CNRS Laboratory of Immunology and Therapeutic Chemistry in Strasbourg, and then the Strasbourg Institute of Medicines beginning in 2011. There, she conducted research at the intersection of biology, chemistry, and medicine, with a clear goal: to transform fundamental discoveries into concrete solutions for public health.
A recipient of the CNRS Silver Medal (2009) and the CNRS Innovation Medal (2015), Sylviane Muller has also been awarded numerous prestigious prizes, including the Léon Velluz Prize from the Academy of Sciences, the Arthritis Foundation Innovation Award, and a finalist for the European Inventor Award, among others.
Elected to the Academia Europaea and the European Academy of Sciences (EURASC), she is also an Officer of the Legion of Honor. Her appointment to the Academy of Sciences in early 2026 marks the culmination of an exemplary career characterized by dedication, scientific rigor, and a passion for research.
DONATIONS
MAKE A DONATION
